Company / Operating Income per Share
Oric Pharmaceuticals, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.63
FY2025
5-year range
-$2.31 / -$1.63
FY2021-FY2025
Trend
+20.5%
vs FY2024
Sector context
#104 of 201
Health Care
What the data says
At $-1.63, Oric Pharmaceuticals, Inc.'s operating income per share ranks #104 of 201 in the Health Care sector. Operating Income per Share has increased for 3 consecutive years, from $-2.31 in FY2022 to $-1.63 in FY2025.
Based on SEC 10-K filings.
-1.63 in FY2025.
Improved from $-2.15 to $-1.63 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 201 in Health CareTop 52% of 201This company -$1.63 Sector average -$28.56
▼
+94.3% above sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s operating income per share has grown for 3 consecutive years.
- In FY2025, operating income per share increased 20.5% year-over-year.
- Ranks #104 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.63 | +20.5% |
| FY2024 | -$2.05 | +4.8% |
| FY2023 | -$2.15 | +7.0% |
| FY2022 | -$2.31 | -11.4% |
| FY2021 | -$2.08 | +38.5% |
| FY2020 | -$3.38 | +77.5% |
| FY2019 | -$15.04 | -16.6% |
| FY2018 | -$12.90 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026